▶ 調査レポート

ヒト成長ホルモンの世界市場レポート2020

• 英文タイトル:Global Human Somatotropin Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。ヒト成長ホルモンの世界市場レポート2020 / Global Human Somatotropin Sales Market Report 2020 / 20QY06-03006資料のイメージです。• レポートコード:20QY06-03006
• 出版社/出版日:QYResearch / 2020年6月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、147ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、ヒト成長ホルモンのグローバル市場について種類別(粉末、溶剤)、用途別(成長ホルモン欠乏症(GHD)、ターナー症候群、慢性腎不全、プラダー・ウィリー症候群、在胎不当過小児、SHOX欠乏症、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・ヒト成長ホルモン市場の概要
・世界の主要地域別ヒト成長ホルモン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のヒト成長ホルモン市場規模2015-2026:種類別(粉末、溶剤)
・世界のヒト成長ホルモン市場規模2015-2026:用途別(成長ホルモン欠乏症(GHD)、ターナー症候群、慢性腎不全、プラダー・ウィリー症候群、在胎不当過小児、SHOX欠乏症、その他)
・ヒト成長ホルモンの北米市場規模2015-2020
・ヒト成長ホルモンのヨーロッパ市場規模2015-2020
・ヒト成長ホルモンの中国市場規模2015-2020
・ヒト成長ホルモンの日本市場規模2015-2020
・ヒト成長ホルモンの東南アジア市場規模2015-2020
・ヒト成長ホルモンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Novo Nordisk、Pfizer、Eli Lilly、Merck Serono、F. Hoffmann-La Roche、Ferring Pharmaceuticals、GeneScience Pharmaceuticals、Ipsen、LG Life Sciences、Sandoz International、Anhui Anke Biotechnology)
・ヒト成長ホルモンの製造コスト分析
・販売チャネル、流通業者、顧客
・ヒト成長ホルモンの市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Human Somatotropin Market
The global Human Somatotropin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Human Somatotropin Scope and Market Size
The global Human Somatotropin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Somatotropin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Human Somatotropin market is segmented into
Powder
Solvent

Segment by Application, the Human Somatotropin market is segmented into
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
The Human Somatotropin market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Somatotropin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Somatotropin Market Share Analysis
Human Somatotropin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Somatotropin business, the date to enter into the Human Somatotropin market, Human Somatotropin product introduction, recent developments, etc.
The major vendors covered:
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology

レポート目次

Table of Contents

1 Human Somatotropin Market Overview
1.1 Human Somatotropin Product Scope
1.2 Human Somatotropin Segment by Type
1.2.1 Global Human Somatotropin Sales by Type (2020-2026)
1.2.2 Powder
1.2.3 Solvent
1.3 Human Somatotropin Segment by Application
1.3.1 Global Human Somatotropin Sales Comparison by Application (2020-2026)
1.3.2 Growth Hormone Deficiency (GHD)
1.3.3 Turner Syndrome
1.3.4 Chronic Renal Insufficiency
1.3.5 Prader Willi Syndrome
1.3.6 Small for Gestational Age
1.3.7 SHOX Deficiency
1.3.8 Others
1.4 Human Somatotropin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Human Somatotropin Sales Growth Rate (2015-2026)
1.4.2 Global Human Somatotropin Revenue and Growth Rate (2015-2026)
1.4.3 Global Human Somatotropin Price Trends (2015-2026)

2 Human Somatotropin Estimate and Forecast by Region
2.1 Global Human Somatotropin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Human Somatotropin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Human Somatotropin Sales Market Share by Region (2015-2020)
2.2.2 Global Human Somatotropin Revenue Market Share by Region (2015-2020)
2.3 Global Human Somatotropin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Human Somatotropin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Human Somatotropin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Somatotropin Estimates and Projections (2015-2026)
2.4.2 Europe Human Somatotropin Estimates and Projections (2015-2026)
2.4.3 China Human Somatotropin Estimates and Projections (2015-2026)
2.4.4 Japan Human Somatotropin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Human Somatotropin Estimates and Projections (2015-2026)
2.4.6 India Human Somatotropin Estimates and Projections (2015-2026)
3 Global Human Somatotropin Competition Landscape by Players
3.1 Global Top Human Somatotropin Players by Sales (2015-2020)
3.2 Global Top Human Somatotropin Players by Revenue (2015-2020)
3.3 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Somatotropin as of 2019)
3.4 Global Human Somatotropin Average Price by Company (2015-2020)
3.5 Manufacturers Human Somatotropin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Human Somatotropin Players (Opinion Leaders)
4 Global Human Somatotropin Market Size by Type
4.1 Global Human Somatotropin Historic Market Review by Type (2015-2020)
4.1.1 Global Human Somatotropin Sales Market Share by Type (2015-2020)
4.1.2 Global Human Somatotropin Revenue Market Share by Type (2015-2020)
4.1.3 Global Human Somatotropin Price by Type (2014-2020)
4.2 Global Human Somatotropin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Human Somatotropin Sales Forecast by Type (2021-2026)
4.2.2 Global Human Somatotropin Revenue Forecast by Type (2021-2026)
4.2.3 Global Human Somatotropin Price Forecast by Type (2021-2026)
5 Global Human Somatotropin Market Size by Application
5.1 Global Human Somatotropin Historic Market Review by Application (2015-2020)
5.1.1 Global Human Somatotropin Sales Market Share by Application (2015-2020)
5.1.2 Global Human Somatotropin Revenue Market Share by Application (2015-2020)
5.1.3 Global Human Somatotropin Price by Application (2015-2020)
5.2 Global Human Somatotropin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Human Somatotropin Sales Forecast by Application (2021-2026)
5.2.2 Global Human Somatotropin Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Somatotropin Price Forecast by Application (2021-2026)

3 North America Human Somatotropin Market Facts & Figures
3.2 North America Human Somatotropin Sales Market Share by Company (2015-2020)
3.3 North America Human Somatotropin Sales Market Share by Type (2015-2020)
3.4 North America Human Somatotropin Sales Market Share by Application (2015-2020)

4 Europe Human Somatotropin Market Facts & Figures
4.2 Europe Human Somatotropin Sales Market Share by Company (2015-2020)
4.3 Europe Human Somatotropin Sales Market Share by Type (2015-2020)
4.4 Europe Human Somatotropin Sales Market Share by Application (2015-2020)

5 China Human Somatotropin Market Facts & Figures
5.2 China Human Somatotropin Sales Market Share by Company (2015-2020)
5.3 China Human Somatotropin Sales Market Share by Type (2015-2020)
5.4 China Human Somatotropin Sales Market Share by Application (2015-2020)

6 Japan Human Somatotropin Market Facts & Figures
6.2 Japan Human Somatotropin Sales Market Share by Company (2015-2020)
6.3 Japan Human Somatotropin Sales Market Share by Type (2015-2020)
6.4 Japan Human Somatotropin Sales Market Share by Application (2015-2020)

7 Southeast Asia Human Somatotropin Market Facts & Figures
7.2 Southeast Asia Human Somatotropin Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Human Somatotropin Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Human Somatotropin Sales Market Share by Application (2015-2020)

8 India Human Somatotropin Market Facts & Figures
8.2 India Human Somatotropin Sales Market Share by Company (2015-2020)
8.3 India Human Somatotropin Sales Market Share by Type (2015-2020)
8.4 India Human Somatotropin Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Human Somatotropin Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Human Somatotropin Corporation Information
12.1.2 Novo Nordisk Human Somatotropin Business Overview and Total Revenue
12.1.3 Novo Nordisk Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novo Nordisk Human Somatotropin Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Pfizer
12.2.1 Pfizer Human Somatotropin Corporation Information
12.2.2 Pfizer Human Somatotropin Business Overview and Total Revenue
12.2.3 Pfizer Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Human Somatotropin Products Offered
12.2.5 Pfizer Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Human Somatotropin Corporation Information
12.3.2 Eli Lilly Human Somatotropin Business Overview and Total Revenue
12.3.3 Eli Lilly Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eli Lilly Human Somatotropin Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Merck Serono
12.4.1 Merck Serono Human Somatotropin Corporation Information
12.4.2 Merck Serono Human Somatotropin Business Overview and Total Revenue
12.4.3 Merck Serono Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck Serono Human Somatotropin Products Offered
12.4.5 Merck Serono Recent Development
12.5 F. Hoffmann-La Roche
12.5.1 F. Hoffmann-La Roche Human Somatotropin Corporation Information
12.5.2 F. Hoffmann-La Roche Human Somatotropin Business Overview and Total Revenue
12.5.3 F. Hoffmann-La Roche Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 F. Hoffmann-La Roche Human Somatotropin Products Offered
12.5.5 F. Hoffmann-La Roche Recent Development
12.6 Ferring Pharmaceuticals
12.6.1 Ferring Pharmaceuticals Human Somatotropin Corporation Information
12.6.2 Ferring Pharmaceuticals Human Somatotropin Business Overview and Total Revenue
12.6.3 Ferring Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ferring Pharmaceuticals Human Somatotropin Products Offered
12.6.5 Ferring Pharmaceuticals Recent Development
12.7 GeneScience Pharmaceuticals
12.7.1 GeneScience Pharmaceuticals Human Somatotropin Corporation Information
12.7.2 GeneScience Pharmaceuticals Human Somatotropin Business Overview and Total Revenue
12.7.3 GeneScience Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GeneScience Pharmaceuticals Human Somatotropin Products Offered
12.7.5 GeneScience Pharmaceuticals Recent Development
12.8 Ipsen
12.8.1 Ipsen Human Somatotropin Corporation Information
12.8.2 Ipsen Human Somatotropin Business Overview and Total Revenue
12.8.3 Ipsen Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ipsen Human Somatotropin Products Offered
12.8.5 Ipsen Recent Development
12.9 LG Life Sciences
12.9.1 LG Life Sciences Human Somatotropin Corporation Information
12.9.2 LG Life Sciences Human Somatotropin Business Overview and Total Revenue
12.9.3 LG Life Sciences Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 LG Life Sciences Human Somatotropin Products Offered
12.9.5 LG Life Sciences Recent Development
12.10 Sandoz International
12.10.1 Sandoz International Human Somatotropin Corporation Information
12.10.2 Sandoz International Human Somatotropin Business Overview and Total Revenue
12.10.3 Sandoz International Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Sandoz International Human Somatotropin Products Offered
12.10.5 Sandoz International Recent Development
12.11 Anhui Anke Biotechnology
12.11.1 Anhui Anke Biotechnology Human Somatotropin Corporation Information
12.11.2 Anhui Anke Biotechnology Human Somatotropin Business Overview and Total Revenue
12.11.3 Anhui Anke Biotechnology Human Somatotropin Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Anhui Anke Biotechnology Human Somatotropin Products Offered
12.11.5 Anhui Anke Biotechnology Recent Development

13 Human Somatotropin Manufacturing Cost Analysis
13.1 Human Somatotropin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Somatotropin
13.4 Human Somatotropin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Somatotropin Distributors List
14.3 Human Somatotropin Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Human Somatotropin Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Human Somatotropin Sales (MT) Comparison by Application (2020-2026)
Table 3. Global Market Human Somatotropin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Human Somatotropin Sales (MT) by Region (2015-2020)
Table 5. Global Human Somatotropin Sales Market Share by Region (2015-2020)
Table 6. Global Human Somatotropin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Human Somatotropin Revenue Share by Region (2015-2020)
Table 8. Global Human Somatotropin Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Human Somatotropin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Human Somatotropin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Human Somatotropin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Human Somatotropin (MT) of Key Companies (2015-2020)
Table 13. Global Human Somatotropin Sales Share by Company (2015-2020)
Table 14. Global Human Somatotropin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Human Somatotropin Revenue Share by Company (2015-2020)
Table 16. Global Human Somatotropin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Somatotropin as of 2019)
Table 17. Global Human Somatotropin Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Human Somatotropin Manufacturing Sites and Area Served
Table 19. Manufacturers Human Somatotropin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Human Somatotropin Players
Table 22. Global Human Somatotropin Sales (MT) by Type (2015-2020)
Table 23. Global Human Somatotropin Sales Share by Type (2015-2020)
Table 24. Global Human Somatotropin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Human Somatotropin Price (MT) by Type (2015-2020)
Table 26. Global Human Somatotropin Sales Share by Type (2021-2026)
Table 27. Global Human Somatotropin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Human Somatotropin Revenue Share by Type (2021-2026)
Table 29. Global Human Somatotropin Price (MT) by Type (2021-2026)
Table 30. Global Human Somatotropin Sales (MT) by Application (2015-2020)
Table 31. Global Human Somatotropin Sales Share by Application (2015-2020)
Table 32. Global Human Somatotropin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Human Somatotropin Price (MT) by Application (2015-2020)
Table 34. Global Human Somatotropin Sales (MT) by Application (2021-2026)
Table 35. Global Human Somatotropin Sales Share by Application (2021-2026)
Table 36. Global Human Somatotropin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Human Somatotropin Revenue Share by Application (2021-2026)
Table 38. Global Human Somatotropin Price (MT) by Application (2021-2026)
Table 39. United States Human Somatotropin Sales (MT) by Company (2015-2020)
Table 40. United States Human Somatotropin Sales Market Share by Company (2015-2020)
Table 41. United States Human Somatotropin Sales (MT) by Type (2015-2020)
Table 42. United States Human Somatotropin Sales Market Share by Type (2015-2020)
Table 43. United States Human Somatotropin Sales (MT) by Application (2015-2020)
Table 44. United States Human Somatotropin Sales Market Share by Application (2015-2020)
Table 45. Europe Human Somatotropin Sales (MT) by Company (2015-2020)
Table 46. Europe Human Somatotropin Sales Market Share by Company (2015-2020)
Table 47. Europe Human Somatotropin Sales (MT) by Type (2015-2020)
Table 48. Europe Human Somatotropin Sales Market Share by Type (2015-2020)
Table 49. Europe Human Somatotropin Sales (MT) by Application (2015-2020)
Table 50. Europe Human Somatotropin Sales Market Share by Type (2015-2020)
Table 51. China Human Somatotropin Sales (MT) by Company (2015-2020)
Table 52. China Human Somatotropin Sales Market Share by Company (2015-2020)
Table 53. China Human Somatotropin Sales (MT) by Type (2015-2020)
Table 54. China Human Somatotropin Sales Market Share by Type (2015-2020)
Table 55. China Human Somatotropin Sales (MT) by Application (2015-2020)
Table 56. China Human Somatotropin Sales Market Share by Application (2015-2020)
Table 57. Japan Human Somatotropin Sales (MT) by Company (2015-2020)
Table 58. Japan Human Somatotropin Sales Market Share by Company (2015-2020)
Table 59. Japan Human Somatotropin Sales (MT) by Type (2015-2020)
Table 60. Japan Human Somatotropin Sales Market Share by Type (2015-2020)
Table 61. Japan Human Somatotropin Sales (MT) by Application (2015-2020)
Table 62. Japan Human Somatotropin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Human Somatotropin Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Human Somatotropin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Human Somatotropin Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Human Somatotropin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Human Somatotropin Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Human Somatotropin Sales Market Share by Application (2015-2020)
Table 69. India Human Somatotropin Sales (MT) by Company (2015-2020)
Table 70. India Human Somatotropin Sales Market Share by Company (2015-2020)
Table 71. India Human Somatotropin Sales (MT) by Type (2015-2020)
Table 72. India Human Somatotropin Sales Market Share by Type (2015-2020)
Table 73. India Human Somatotropin Sales (MT) by Application (2015-2020)
Table 74. India Human Somatotropin Sales Market Share by Application (2015-2020)
Table 75. Novo Nordisk Corporation Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Novo Nordisk Human Somatotropin Product
Table 79. Novo Nordisk Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pfizer Human Somatotropin Product
Table 84. Pfizer Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Eli Lilly Human Somatotropin Product
Table 89. Eli Lilly Recent Development
Table 90. Merck Serono Corporation Information
Table 91. Merck Serono Description and Business Overview
Table 92. Merck Serono Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Merck Serono Human Somatotropin Product
Table 94. Merck Serono Recent Development
Table 95. F. Hoffmann-La Roche Corporation Information
Table 96. F. Hoffmann-La Roche Description and Business Overview
Table 97. F. Hoffmann-La Roche Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. F. Hoffmann-La Roche Human Somatotropin Product
Table 99. F. Hoffmann-La Roche Recent Development
Table 100. Ferring Pharmaceuticals Corporation Information
Table 101. Ferring Pharmaceuticals Description and Business Overview
Table 102. Ferring Pharmaceuticals Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Ferring Pharmaceuticals Human Somatotropin Product
Table 104. Ferring Pharmaceuticals Recent Development
Table 105. GeneScience Pharmaceuticals Corporation Information
Table 106. GeneScience Pharmaceuticals Description and Business Overview
Table 107. GeneScience Pharmaceuticals Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. GeneScience Pharmaceuticals Human Somatotropin Product
Table 109. GeneScience Pharmaceuticals Recent Development
Table 110. Ipsen Corporation Information
Table 111. Ipsen Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Ipsen Description and Business Overview
Table 113. Ipsen Human Somatotropin Product
Table 114. Ipsen Recent Development
Table 115. LG Life Sciences Corporation Information
Table 116. LG Life Sciences Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. LG Life Sciences Description and Business Overview
Table 118. LG Life Sciences Human Somatotropin Product
Table 119. LG Life Sciences Recent Development
Table 120. Sandoz International Corporation Information
Table 121. Sandoz International Description and Business Overview
Table 122. Sandoz International Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Sandoz International Human Somatotropin Product
Table 124. Sandoz International Recent Development
Table 125. Anhui Anke Biotechnology Corporation Information
Table 126. Anhui Anke Biotechnology Description and Business Overview
Table 127. Anhui Anke Biotechnology Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Anhui Anke Biotechnology Human Somatotropin Product
Table 129. Anhui Anke Biotechnology Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Human Somatotropin Distributors List
Table 133. Human Somatotropin Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Somatotropin Product Picture
Figure 2. Global Human Somatotropin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Somatotropin Market Share by Application in 2020 & 2026
Figure 6. Growth Hormone Deficiency (GHD) Examples
Figure 7. Turner Syndrome Examples
Figure 8. Chronic Renal Insufficiency Examples
Figure 9. Prader Willi Syndrome Examples
Figure 10. Small for Gestational Age Examples
Figure 11. SHOX Deficiency Examples
Figure 12. Others Examples
Figure 13. Global Human Somatotropin Sales (MT) Growth Rate (2015-2026)
Figure 14. Global Human Somatotropin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 15. Global Human Somatotropin Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 16. Global Human Somatotropin Revenue Market Share by Region: 2015 VS 2020
Figure 17. Global Human Somatotropin Revenue Market Share by Region: 2021 VS 2026
Figure 18. United States Human Somatotropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. United States Human Somatotropin Sales (MT) Growth Rate (2015-2026)
Figure 20. Europe Human Somatotropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Europe Human Somatotropin Sales (Million USD) Growth Rate (2015-2026)
Figure 22. China Human Somatotropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. China Human Somatotropin Sales (Million USD) and Growth Rate (2015-2026)
Figure 24. Japan Human Somatotropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Japan Human Somatotropin Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Human Somatotropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia Human Somatotropin Sales (Million USD) Growth Rate (2015-2026)
Figure 28. India Human Somatotropin Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. India Human Somatotropin Sales (Million USD) Growth Rate (2015-2026)
Figure 30. Global 5 Largest Human Somatotropin Players Market Share by Revenue in Human Somatotropin 2015 & 2019
Figure 31. Human Somatotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 32. Global Human Somatotropin Revenue Share by Type (2015-2020)
Figure 33. Global Human Somatotropin Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Global Human Somatotropin Revenue Share by Application (2015-2020)
Figure 35. Global Human Somatotropin Revenue Growth Rate by Application in 2015 & 2019
Figure 36. United States Human Somatotropin Sales Market Share by Type in 2019
Figure 37. United States Human Somatotropin Sales Market Share by Type in 2019
Figure 38. Europe Human Somatotropin Sales Market Share by Company in 2019
Figure 39. Europe Human Somatotropin Sales Market Share by Type in 2019
Figure 40. Europe Human Somatotropin Sales Market Share by Application in 2019
Figure 41. China Human Somatotropin Sales Market Share by Company in 2019
Figure 42. China Human Somatotropin Sales Market Share by Type in 2019
Figure 43. China Human Somatotropin Sales Market Share by Application in 2019
Figure 44. Japan Human Somatotropin Sales Market Share by Company in 2019
Figure 45. Japan Human Somatotropin Sales Market Share by Type in 2019
Figure 46. Japan Human Somatotropin Sales Market Share by Application in 2019
Figure 47. Southeast Asia Human Somatotropin Sales Market Share by Company in 2019
Figure 48. Southeast Asia Human Somatotropin Sales Market Share by Type in 2019
Figure 49. Southeast Asia Human Somatotropin Sales Market Share by Application in 2019
Figure 50. India Human Somatotropin Sales Market Share by Company in 2019
Figure 51. India Human Somatotropin Sales Market Share by Type in 2019
Figure 52. India Human Somatotropin Sales Market Share by Application in 2019
Figure 53. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merck Serono Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Ferring Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. GeneScience Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Sandoz International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Anhui Anke Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Human Somatotropin
Figure 66. Manufacturing Process Analysis of Human Somatotropin
Figure 67. Human Somatotropin Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed